X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (447) 447
Book Review (35) 35
Publication (13) 13
Dissertation (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (318) 318
vp-16 (308) 308
humans (280) 280
oncology (231) 231
etoposide (171) 171
male (154) 154
female (150) 150
etoposide - administration & dosage (138) 138
antineoplastic combined chemotherapy protocols - therapeutic use (118) 118
cisplatin (107) 107
adult (105) 105
chemotherapy (103) 103
middle aged (101) 101
aged (74) 74
lung neoplasms - drug therapy (73) 73
etoposide - pharmacology (69) 69
animals (59) 59
cancer (56) 56
carcinoma, small cell - drug therapy (56) 56
antineoplastic combined chemotherapy protocols - adverse effects (54) 54
pharmacology & pharmacy (54) 54
apoptosis (53) 53
etoposide vp-16 (52) 52
therapy (51) 51
cisplatin - administration & dosage (49) 49
etoposide - adverse effects (49) 49
adolescent (42) 42
drug administration schedule (42) 42
hematology (42) 42
etoposide - therapeutic use (41) 41
mice (40) 40
carcinoma (39) 39
combined modality therapy (38) 38
tumor cells, cultured (38) 38
treatment outcome (37) 37
biochemistry & molecular biology (34) 34
child (33) 33
cyclophosphamide (33) 33
administration, oral (32) 32
carboplatin (32) 32
carboplatin - administration & dosage (32) 32
survival analysis (32) 32
trial (31) 31
salvage therapy (30) 30
dose-response relationship, drug (29) 29
doxorubicin (28) 28
drug resistance (28) 28
combination chemotherapy (27) 27
vincristine (27) 27
child, preschool (26) 26
phase-ii trial (26) 26
remission induction (25) 25
survival rate (25) 25
antineoplastic agents, phytogenic - pharmacology (24) 24
cyclophosphamide - administration & dosage (24) 24
cytotoxicity (24) 24
vincristine - administration & dosage (24) 24
dna damage (23) 23
transplantation (23) 23
antineoplastic combined chemotherapy protocols - administration & dosage (22) 22
cell biology (22) 22
ifosfamide - administration & dosage (22) 22
lung neoplasms - mortality (22) 22
randomized trial (22) 22
topoisomerase ii inhibitors (22) 22
tumors (22) 22
bone-marrow transplantation (21) 21
carcinoma, small cell - mortality (21) 21
etoposide - pharmacokinetics (21) 21
lung neoplasms - pathology (21) 21
multidrug resistance (21) 21
small cell lung cancer (21) 21
bone marrow transplantation (20) 20
cell survival - drug effects (20) 20
dna topoisomerases, type ii - metabolism (20) 20
etoposide - toxicity (20) 20
pharmacokinetics (20) 20
topoisomerase ii (20) 20
apoptosis - drug effects (19) 19
cell line (19) 19
cell lung-cancer (19) 19
children (19) 19
combination (19) 19
expression (19) 19
phase-ii (19) 19
prognosis (19) 19
infusions, intravenous (18) 18
neoplasm recurrence, local - drug therapy (18) 18
p-glycoprotein (18) 18
abridged index medicus (17) 17
antineoplastic agents, phytogenic - therapeutic use (17) 17
dna (17) 17
multidrug-resistance (17) 17
pediatrics (17) 17
toxicity (17) 17
antineoplastic agents, phytogenic - administration & dosage (16) 16
brain neoplasms - drug therapy (16) 16
disease-free survival (16) 16
drug resistance, neoplasm (16) 16
immunology (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 07/2019, Volume 25, Issue 7, pp. 1304 - 1311
We conducted a retrospective study of 62 patients undergoing etoposide (2 g/m ) + granulocyte colony-stimulating factor (G-CSF; 10 patients also received... 
Etoposide | VP-16 | Mobilization | Salvage | Plerixafor | Chemomobilization | Medical research | Executives | Granulocyte colony-stimulating factor | Stem cells | Medicine, Experimental | Transplantation
Journal Article
THE SHINSHU MEDICAL JOURNAL, ISSN 0037-3826, 2016, Volume 64, Issue 5, pp. 247 - 252
A 69-year-old man was referred to our hospital because of occasional nosebleeds over a period of 6 months. Physical examinations were unremarkable except for... 
VP-16 | radiotherapy | chemoradiotherapy | cisplatin | epistaxis
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 43, pp. 73884 - 73891
miR-302a have been reported to participate in various physiological and pathological processes, however, a role for miR-302a in etoposide (VP-16) resistance of... 
VP-16 resistance | Rad52 | Acute myeloid leukemia (AML) | miR-302a | acute myeloid leukemia (AML) | AKT | ACUTE MYELOID-LEUKEMIA | MICRORNAS | CANCER | CELL BIOLOGY
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 01/2015, Volume 46, pp. 253 - 263
We constructed a novel core–shell structured Fe O @ZnO:Er ,Yb @(β-CD) nanoparticles used as drug carrier to investigate the loading and controllable release... 
Fe3O4@ZnO:Er3 +,Yb3 +@(β-CD) | Microwave-triggered | Controlled drug release | Up-conversion luminescence | Magnetic properties | NANOPARTICLES | IN-VITRO | NANOCOMPOSITES | MATERIALS SCIENCE, BIOMATERIALS | Fe3O4@ZnO:Er3+,Yb3+@(beta-CD) | CYCLODEXTRIN | HOLLOW | VP-16
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 7/2012, Volume 20, Issue 14, pp. 4489 - 4494
Two conjugates ( 1 and 2 ) of camptothecin (CPT) and 4β-anilino-4′- O -demethylepipodophyllotoxin were previously shown to exert antitumor activity through... 
Topoisomerase | etoposide (VP-16) | epipodophyllotoxin | conjugates | camptothecin (CPT) | cytotoxicity
Journal Article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ISSN 1083-8791, 07/2019, Volume 25, Issue 7, pp. 1304 - 1311
We conducted a retrospective study of 62 patients undergoing etoposide (2 g/m(2)) + granulocyte colony-stimulating factor (G-CSF; 10 patients also received... 
MULTIPLE-MYELOMA | Plerixafor | Etoposide | IMMUNOLOGY | G-CSF | STEM-CELL MOBILIZATION | BLOOD PROGENITOR CELLS | CHEMOTHERAPY | Chemomobilization | TRANSPLANTATION | Mobilization | Salvage | VP-16 | NON-HODGKINS-LYMPHOMA | MOBILIZERS | HEMATOLOGY | HIGH-DOSE ETOPOSIDE | HEMATOPOIETIC STEM
Journal Article
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 43, pp. 70715 - 70737
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 03/2005, Volume 67, Issue 3, pp. 937 - 947
Cisplatin was shown to strongly inhibit the decatenation and relaxation activity of isolated human DNA topoisomerase IIalpha. This inhibition was not... 
DEXRAZOXANE ICRF-187 | POTENT INHIBITOR | RESISTANT | ETOPOSIDE VP-16 | KINETICS | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | LEUKEMIA K562 CELLS | CATALYTIC INHIBITOR | BINDING
Journal Article
Oncology Letters, ISSN 1792-1074, 06/2017, Volume 13, Issue 6, pp. 4077 - 4084
Etoposide (VP16) combined with cisplatin (DDP), as the first-line chemotherapy for small cell lung cancer (SCLC), regularly confers drug resistance. The... 
Platinol | VP-16 | Small cell lung cancer | Multidrug resistance | Gene chips | multidrug resistance | APOPTOSIS | METASTASIS | DOWN-REGULATION | PROLIFERATION | platinol | PLAYERS | GENE | ONCOLOGY | small cell lung cancer | MUTATIONS | MULTIDRUG-RESISTANCE | CARCINOMA | gene chips | MICRORNA
Journal Article
Journal of Dalian Medical University, ISSN 1671-7295, 06/2011, Volume 33, Issue 3, pp. 211 - 215
Journal Article
Journal Article
Journal Article